Palantir Technologies has faced increasing scrutiny from MPs from various parties over information security issues relating to its involvement with the NHS, as the American-based analytics firm defends its £300m agreement with NHS England. The dispute intensified following guidance sent to every NHS trust in England directing them to use Palantir’s “core products” in hospitals starting this month, according to the British Medical Journal. Labour MP Emily Darlington has warned that engaging a overseas technology firm with medical information constitutes a major security risk, whilst the Liberal Democrats have stated the firm ought to be kept away from our national security infrastructure. The Green Party and Conservative MPs have also demanded heightened scrutiny of the company’s information protection capabilities, as Palantir’s UK leadership insists the software presents no risk to patient information.
The debate involving a US tech firm’s NHS involvement
The backlash against Palantir’s involvement with the NHS revolves around concerns about entrusting a overseas tech firm with sensitive patient data. Critics argue that relying on a US-headquartered firm for such essential health system infrastructure poses significant security concerns, particularly given the company’s prior associations to defence and intelligence activities. The timing of this dispute is important, as NHS trusts have been directed to implement Palantir’s systems this month, creating uncertainty about whether adequate protections and parliamentary scrutiny were in place before such widespread deployment commenced across the health service.
Palantir’s UK leadership team has moved swiftly to address these concerns, with executives stressing that the company has no business incentive to accessing or utilising patient data. The firm maintains that its Foundry platform functions much like commonly-deployed applications like Microsoft Office, which handles NHS information without the software provider obtaining it. Nevertheless, the scale of parliamentary resistance—spanning Labour, Liberal Democrat, Green, and Conservative MPs—indicates that reassurances from company officials alone may fall short to quell parliamentary concerns about data sovereignty and security protocols.
- Labour MP Emily Darlington cautioned against “substantial security concern” from international tech involvement
- Liberal Democrats declared organisation “should be nowhere near our national security infrastructure”
- Green Party leader described Palantir “a military surveillance company”
- Conservative MP Wendy Morton demanded scrutiny of data security measures
What Palantir offers and why the NHS needs it
Palantir’s Foundry platform tackles a persistent issue that has beset the NHS for many years: the inability of distinct healthcare systems to interact seamlessly with one another. Across the NHS, separate databases exist in isolation—a patient’s GP records cannot readily connect with their hospital files, and clinic systems work in isolation from A&E departments. This fragmentation generates delays, delays treatment decisions, and depletes essential capacity. The £300 million contract awarded to Palantir at the close of 2023 is designed to solve this vital technical issue by building a consolidated data system.
The company’s software permits NHS trusts to retrieve, consolidate and examine historically separate databases whilst avoiding high-cost upgrades or renewals. By linking these separate infrastructures, Palantir claims its platform offers measurable improvements: it delivers live oversight of waiting lists, monitors medical inventory and assets, identifies available beds and operating theatres, and substantially advances patient care coordination. These capabilities tackle real workflow challenges that healthcare professionals and leadership experience daily. The technology constitutes a realistic effort to update healthcare systems while maintaining established expenditure in older platforms.
How the distributed data platform works
Rather than forcing the NHS to consolidate or replace its existing IT systems, Palantir’s federated data platform functions as a connective layer between distinct systems. It allows information held in different databases—whether at GP surgeries, hospitals or clinics—to be analysed and accessed together without transferring or centralising the data itself. This “distributed” approach means each organisation retains control of its own information whilst allowing analysis and cross-system queries. The platform serves as a complex intermediary, permitting incompatible systems to communicate insights without necessitating full technological overhaul.
Palantir executives have repeatedly made comparisons to common office software to describe the technology’s operation. Just as Microsoft Excel or Word processes NHS data without Microsoft gaining access to it, Palantir’s software combines information without the company itself accessing patient records. The data remains under NHS control and ownership throughout the process. This structural approach is at the heart of the company’s response to security allegations, though critics challenge whether such guarantees are adequate given the confidential nature of healthcare information and Palantir’s prior involvement with military and intelligence agencies.
Political resistance spans the breadth
| Party | Key concern |
|---|---|
| Labour | Foreign tech company involvement with patient data poses major security risk |
| Liberal Democrats | Palantir should not be involved with national security infrastructure |
| Green Party | Company’s background as military surveillance firm raises fundamental concerns |
| Conservative Party | Insufficient scrutiny of the company’s data protection capabilities |
| Cross-party MPs | General demand for enhanced oversight of NHS data usage agreements |
The backlash against Palantir’s NHS involvement has proven notably bipartisan, with politicians across the political spectrum voicing significant concerns. Labour MP Emily Darlington warned the BBC that entrusting a foreign technology company with sensitive patient information represents “a significant security threat”, whilst Conservative MP Wendy Morton has called for greater scrutiny of the firm’s information security capabilities. The Liberal Democrats have taken an stronger stance, arguing that Palantir “should be nowhere near our national security infrastructure”, whilst Green Party leader Zack Polanski has highlighted the company’s troubled past, labelling it “a defence monitoring company”. This unusual political consensus suggests authentic worry extends beyond partisan positioning.
Palantir’s position and the government’s stance
Palantir has launched a strong defence against the growing criticism, with UK executive vice-chair Louis Mosley speaking to the BBC’s Politics Live to address concerns head-on. Mosley welcomed parliamentary scrutiny, voicing confidence that the company was “serving” patients through its Foundry data-sharing platform. He stressed that Palantir has no financial incentive to obtain patient data, comparing the arrangement to established software like Microsoft Excel or email used throughout the NHS. As Mosley explained, the company operates under clear legal parameters that prohibit data access, making patient information protection a non-issue rather than a vulnerability.
The government has primarily endorsed Palantir’s involvement, with Labour MP Alex McIntyre, sitting on the Commons Health and Social Care select committee, supporting the agreement whilst demanding strict safeguards. McIntyre highlighted that the government has put in place “red lines” ensuring data stays within the UK and under NHS ownership, with Palantir strictly banned from accessing or sharing patient records. This position demonstrates the administration’s belief that the contract’s gains from merging fragmented NHS systems surpass security concerns, as long as robust governance frameworks remain in place. The government’s stance points to confidence in the contractual arrangements, though this remains contested by opposition parties.
The company’s core arguments
- Palantir has no commercial interest in obtaining or profiting from UK patient data whatsoever.
- Software connects incompatible NHS databases without company obtaining records.
- Arrangement aligns with how Microsoft tools operate within NHS with no concerns about data access.
What occurs next for NHS information integration
The £300m Palantir contract with NHS England, awarded at the end of 2023, is set for renewal at the start of next year, creating a key turning point for the government’s data consolidation approach. Before that contract renewal, Parliament will probably increase its scrutiny of the agreement, with select committees possibly initiating official investigations into data protection measures and oversight mechanisms. The increasing parliamentary pressure suggests any contract renewal will meet substantial resistance unless the government can provide evidence of comprehensive safeguards and transparent governance structures. The period ahead will be crucial in establishing whether Palantir maintains its primary role in NHS technology infrastructure or whether alternative solutions gain traction.
Meanwhile, NHS trusts have been instructed to implement Palantir’s core products in hospitals from this month onwards, as per guidance issued by NHS England. This implementation moves forward despite the political controversy, suggesting the government remains committed to the integration project. However, the simultaneous parliamentary pressure could compel the Department of Health to undertake further independent security reviews or create new oversight mechanisms prior to contract renewal. The conclusion will probably determine not only the NHS’s digital future but also set precedent for how the UK government approaches partnerships connecting the health service to foreign technology companies.